Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Analysis of the Results of Treatment for Cervical Carcinoma in Limburg (CervixLimburg)

This study is enrolling participants by invitation only.
Maastricht University Medical Center
Atrium Medical Center
Information provided by:
Maastricht Radiation Oncology Identifier:
First received: January 29, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted

Analysis of all women treated for cervical cancer between 2000 and 2008 in Limburg, a province in the south of the Netherlands. Patient characteristics, diagnosis, treatment modalities, complications and survival will be analyzed by record review. Quality of life of the living study population will be assessed using the EORTC QLQ-C30 and QOQ-CX24 questionnaire. Patients will be identified via registration data from the Integraal Kankercentrum Limburg.

Cervical Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Analysis of Treatment and Quality of Life of Women Treated for Cervical Carcinoma FIGO Stage IB-1 to IVb From 2000-2008 in Limburg, a Province in the South of the Netherlands.

Resource links provided by NLM:

Further study details as provided by Maastricht Radiation Oncology:

Estimated Enrollment: 220
Study Start Date: February 2010

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All women diagnosed with cervical cancer FIGO stage IB-1 to IV between 2000 and 2008 in Limburg, a province in the south of the Netherlands.


Inclusion Criteria:

  • cervical cancer FIGO stage IB-1 to IVB
  • Treated in Limburg between 2000 and 2008

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: R.I. Lalisang, Maastricht University Medical Center Identifier: NCT01059695     History of Changes
Other Study ID Numbers: 09-24-09/12
Study First Received: January 29, 2010
Last Updated: January 29, 2010
Health Authority: Netherlands: Medical Ethics Review Committee (METC)

Keywords provided by Maastricht Radiation Oncology:
cervical cancer
quality of life

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms by Site
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Uterine Neoplasms processed this record on November 27, 2014